A fluid dispensing cartridge includes a housing body having a proximal end wall, a distal end wall, a fluid chamber, and a hollow throat portion. The fluid chamber is in fluid communication with the hollow throat portion. The proximal end wall provides a proximal termination of the fluid chamber and the distal end wall provides a distal termination of the hollow throat portion. A plurality of electrical contacts face proximally from the proximal end wall. The fluid dispensing cartridge includes a fluid jetting chip that has a plurality of fluid jetting nozzles.

A device for the delivery and/or application of a therapeutic composition in a delivery form into the rectal and/or vaginal cavity, the device includes an externally wearable pad; a non-absorbent platform for receiving the delivery form of therapeutic composition; and a sheath joining the platform to the pad such that a user's finger can be received in the sheath.

The application relates to an applicator (1) for oral administration of a swallowable object (2), in particular a solid dosage form, to a patient, wherein the applicator comprises a housing (3) having a first opening (4) and a second opening (5), the first opening of the housing being configured to be coupled with a liquid reservoir, in particular a drinking vessel, and the second opening of the housing being configured such that the patient can drink therefrom, and a holder (6) disposed within the housing and configured to accommodate the swallowable object, the holder being further configured to allow the swallowable object to be conveyed towards the second opening of the housing when liquid is flowing through the housing from the first opening to the second opening of the housing.

Intravesical drug delivery devices that include a device body, a number of solid drug tablets, and a retention frame. The device body includes a drug reservoir lumen and a retention frame lumen. The drug tablets is positioned in the drug reservoir lumen, and the retention frame is positioned in the retention frame lumen.

Provided herein are formulations containing copper ions and methods of treating underlying infections and conditions caused by coronavirus, particularly COVID-19, and influenzas, particularly influenza A and/or influenza B using such formulations. Methods of treating the underlying viruses and their resultant conditions using topical copper ion treatments are provided. A topical treatment in its basic form comprises a biocompatible copper ion solution or suspension obtained by leaching of the copper ions from copper metal. The copper ion solution or suspension may be combined with various carriers to form the copper ion treatment including creams or solutions. Methods of making the copper ion solution or suspension from solid copper metal in a biocompatible solution are also provided.

A rectal medication administration device includes a tube, a balloon, a first valved port, and a second valved port. The tube includes a first lumen, a second lumen, and a plurality of holes extending from the first lumen therethrough. The balloon is proximal to the holes, is in communication with the second lumen, and is configured to be inflated to hold the tube in place within a patient's rectum. The first valved port is in communication with the first lumen and opens when connected to a first syringe or infusion set to provide medication transmission therethrough and closes when the first syringe or infusion set is withdrawn. The second valved port is in communication with the second lumen and opens when connected with a second syringe or infusion set to provide fluid to inflate the balloon and closes when the second syringe or infusion set is withdrawn.

Some implementations can include a tampon/suppository hybrid having at least one composition (e.g., pharmaceutical, medicinal plant, herbal composition, vitamin supplementation, and/or essential oil) applied to, attached to, or contained in the tampon (e.g., at or near an insertion point or tip of the tampon). When the tampon/suppository hybrid is inserted, the tampon/suppository hybrid works to provide the composition to the user, for example, to establish/re-establish the microbial flora of the host, while still absorbing secretions and or blood from menstruation flow.

An implantable leadless pacing device and delivery system may comprise an implantable leadless pacing device and a catheter configured to deliver the implantable leadless packing device to a target location. The implantable device may comprise a power source, circuitry operatively coupled to the power source, a housing at least partially enclosing the circuitry, a first electrode secured relative to and offset from a longitudinal axis of the housing and exposed exterior to the housing, and a fixation mechanism secured relative to the housing. The fixation mechanism may comprise at least one tine configured to move between an elongated delivery configuration and a curved deployed configuration and radially offset from the first electrode. The catheter may comprise a distal holding section defining a cavity configured to receive the implantable leadless pacing device.

A medical device, for example a delivery catheter, may include a handle portion, a shaft portion extending distally from the handle portion, a deployment mechanism, and an actuation member positioned on the handle portion. The shaft portion may include a working channel and a distal tip portion having a payload chamber configured to receive a payload, such as a bio-absorbable foam. The distal tip portion may be operatively connected to the working channel. The deployment mechanism may be positioned in the working channel, and may be operable to deploy the payload out from the distal tip portion. The actuation member may be actuatable to operate the deployment mechanism.

Today's suppositories are typically packaged individually for digital administration into the anal canal of a patient. A suppository applicator described herein, which works with individually packaged suppositories, can alternatively be shipped in a prepackaged operational arrangement with a suppository to enable the patient to administer the suppository through use of the applicator in a single operation after opening a hygienic wrapper containing the applicator-suppository combination. A method for manufacturing a suppository includes manufacturing the suppository in the presence of and in contact with an element configured to be used to insert the suppository into a body cavity. The method may include using the element to define a shape of the suppository during the manufacturing. The resulting applicator-suppository combination is more hygienic and easier to handle than the separate applicator and suppository and provides more efficiency from time of opening the packaging to time of commencing administration of the suppository.